TRWR | News

20 Dec Good news! Taiwan Resonant Waves Research Corp. (TRWR) has acquired Australia, EU, Canada and Russia patents for a diabetes glucagon mitigation system

Posted at 09:00h in Uncategorized

Our company has successively acquired patents for a diabetes glucagon mitigation system in Australia, EU, Canada, Russia and South Korea. We are also applying for patents in other countries around the globe.

15 Jun Congrats! TRWR won first place for Innovation at the 2018 RESI (Redefining Early Stage Investments) Conference in Boston.

Posted at 09:00h in Uncategorized

The term minimalism is also used to describe a trend in design and architecture where in the subject is reduced to its necessary elements. Minimalist design has been highly influenced by Japanese traditional design and architecture. In addition, the work of De Stijl artists is...

30 May Great news! Fast Track for Clinical Trial Program has been approved by the Department of Industrial Technology of the Ministry of Economic Affairs (MOEA).

Posted at 09:00h in Uncategorized

After 7 years of hard work and perseverance, our proprietary non-invasive, electroceutical technology for treating and alleviating symptoms associated with type 2 diabetes has been approved by MOEA for R&D subsidies.

30 Apr Taiwan Resonant Waves Research Corp. has been approved by Taiwan Food and Drug Administration (TFDA) to commence clinical trials.

Posted at 15:40h in Uncategorized

Our randomized, double-blind trial is underway at National Taiwan University Hospital, National Cheng Kung University Hospital, and two other medical facilities. Under the investigative leadership of 20 medical professionals, the study is expected to be completed in 2018 and potentially become the world’s first non-invasive electronic medical device used to alleviate symptoms associated with type 2 diabetes.

30 Jul Good news! Taiwan Resonant Waves Research Corp. (TRWR) has acquired the US patent for diabetes glucagon mitigation using an electrical energy wave generator.

Posted at 12:59h in Uncategorized

In mid-2016, we officially acquired the US patent for diabetes glucagon mitigation using an electrical energy wave generator, and have begun patent applications for this technology in 12 other countries. In addition, TRWR has obtained 11 patents in the field of electroceutical technology development around the world.

Home

About

Product

Research

Pipeline

News

Contact

News

20 Dec Good news! Taiwan Resonant Waves Research Corp. (TRWR) has acquired Australia, EU, Canada and Russia patents for a diabetes glucagon mitigation system

15 Jun Congrats! TRWR won first place for Innovation at the 2018 RESI (Redefining Early Stage Investments) Conference in Boston.

30 May Great news! Fast Track for Clinical Trial Program has been approved by the Department of Industrial Technology of the Ministry of Economic Affairs (MOEA).

30 Apr Taiwan Resonant Waves Research Corp. has been approved by Taiwan Food and Drug Administration (TFDA) to commence clinical trials.

30 Jul Good news! Taiwan Resonant Waves Research Corp. (TRWR) has acquired the US patent for diabetes glucagon mitigation using an electrical energy wave generator.

> About

> Research

> Pipeline

> News

> Product

> Contact